Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Stock Rated “Reduce” by Sell-Side Analysts
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has been given a consensus recommendation of “Reduce” by the twenty-one brokerages that are covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and seven have assigned a buy recommendation to the company. […]
18 Oct 10:15 · The Markets Daily